Award notice
Pharmaceutical Products for CDER Research Studies - IDIQ
75F40126D00023
Food and Drug Administration, FDA Office of Acq Grant SVCS. Pharmaceutical Preparation Manufacturing.
Awarded
$4,000,000.00 on the award notice, September 11, 2026, contract 75F40126D00023
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one was awarded in 2026
9 like it are open now in pharmaceutical preparation manufacturing
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052
Department of Veterans Affairs, 250-Network Contract Office 10
Sources soughtNAICS 325412Anywhere in the US36C25027Q0052Closes in 2 daysNov 3 - Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325412Anywhere in the US36C77027Q0010Closes in 2 daysNov 3
Description
As published on SAM.gov.
Award notice.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 11, 2026
Award notice, originally combined synopsis and solicitation
Awarded to We Pharma, Inc. for $4,000,000. SAM.gov, notice 029067a9d94747c3bce74a8dca61bb82
2 revisions on SAM
- September 11, 2026: publish, award notice
- May 11, 2026: publish, combined synopsis and solicitation
Points of contact
- Nick Sartainnick.sartain@fda.hhs.gov3017961988